Trial Information

Summary: Breast Pain in Healthy Women with Fibrocystic Breast Disease

Symbollon Corporation is conducting a study to test the safety and efficacy of an experimental treatment for health premenopausal woman who suffer from breast pain associated with symptomatic fibrocystic breast disease (non cancerous lumps in the breast).

• Be a female aged 18 through 50
• Have breast pain which is caused by symptomatic fibrocystic breast disease
• Have at least one breast lump which measures at least 25% of one breast surface
• Be premenopausal
• Have failed conservative treatment of their condition
• Have moderate to severe pain in baseline evaluation

• Have a history of thyroid disease
• Have non-cyclic breast pain which is not related to menstruation
• Have recently started any hormonal therapy within 6 months of enrollment including birth control hormonal drugs
• Have breast implants
• Are undergoing current treatment with iodine containing drugs, or are allergic to iodine
• Have a history of cancer including breast cancer, except certain skin cancers
• Are pregnant or nursing
• Are currently or recently took any other experimental treatments

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:25 AM